Daily Emollient Use in Infants: A Promising Strategy to Prevent Pediatric Atopic Dermatitis
Highlight
- Daily application of a full-body emollient from early infancy reduces the incidence of physician-diagnosed atopic dermatitis (AD) by age 24 months in a general population of infants.
- The protective effect is more pronounced in infants not considered at high risk for AD, highlighting potential broad applicability.
- Living with a dog appears to enhance the emollient’s protective effect on reducing AD risk.
- Emollient use did not increase cutaneous adverse events, supporting safety in routine pediatric skin care.
Study Background and Disease Burden
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.